Metformin and survival in diabetic patients with breast cancer
ConclusionThere is an association between metformin use and better survival outcome in diabetic breast cancer patients who received metformin during adjuvant chemotherapy. The choice of antidiabetic pharmacotherapy may influence prognosis of this group.
Source: The Journal Of The Egyptian Public Health Association - Category: Global & Universal Tags: Original articles Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Insulin | International Medicine & Public Health | Metformin | Study